BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Alexion Reports Fourth Quarter and Full Year 2018 Results

  4Q18 total revenues of $1,128.8 million, a 24 percent increase over 4Q17 and a 30 percent volume increase

  February 4, 2019

   · 

  27 min read
• Policy

  Aurora Cannabis Partner Radient Technologies Receives Standard Processing License

  Disruptive Technology an Important Component of Aurora’s Derivative Products Strategy

  February 4, 2019

   · 

  7 min read
• Business

  Evogene Appoints Dr. Adrian Percy to Its Board of Directors

  Dr. Percy most recently served as Head of Research & Development for the Crop Science division of Bayer and has broad senior management experience in the agricultural industry

  February 4, 2019

   · 

  3 min read
• Policy

  VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine

  VLP Therapeutics today announced that the U.S. Food and Drug Administration has cleared an investigational new drug application for a clinical trial of the Company’s VLPM01 malaria vaccine.

  February 4, 2019

   · 

  2 min read
• Policy

  Rubicon Organics Awarded Cultivation & Processing Licenses from Health Canada

  Super-Premium, Certified Organic Cannabis Producer

  February 4, 2019

   · 

  5 min read
• Business

  Emmaus Life Sciences Partners with taiba Healthcare to Commercialize Endari™ for Sickle Cell Disease in the Middle East and North Africa Region

  Emmaus Life Sciences, Inc. today that it has entered into an exclusive agreement with taiba Healthcare under which taiba will register, commercialize and distribute Endari™ (L-glutamine oral powder) in certain countries throughout the Middle East and North Africa (MENA) region.

  February 4, 2019

   · 

  7 min read
• BioMidwest

  Exicure to Present at the Immuno-Oncology 360° Conference

  Exicure, Inc. announced today that its CEO, Dr. David Giljohann, will present at the Immuno-Oncology 360° Conference (IO360°) being held February 6-8, 2019 at the Crowne Plaza Times Square in New York City.

  February 4, 2019

   · 

  3 min read
• Business

  Acorda Appoints Peter S. Carbone Senior Vice President, Quality

  Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that Peter S. Carbone has joined the Company as Senior Vice President, Quality.

  February 4, 2019

   · 

  5 min read
• Business

  Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer

  Aratana Therapeutics, Inc. today announced the appointment of Rhonda Hellums as Chief Financial Officer and Treasurer of Aratana effective February 1, 2019.

  February 4, 2019

   · 

  2 min read
• BioMidwest

  Sustainable Bioproducts Announces $33 Million Series A Financing

  Sustainable Bioproducts, a biotechnology company developing a new way to grow edible protein, has raised $33 million in Series A financing from premier venture capital funds and two of the world’s largest food and agribusiness companies.

  February 4, 2019

   · 

  2 min read